Published in Nature on October 24, 1991
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med (2006) 3.16
The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol (2009) 2.80
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med (2003) 2.77
Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med (2004) 2.43
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34
Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest (2001) 2.26
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest (2007) 2.18
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med (2003) 2.09
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood (2009) 2.05
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest (1993) 1.92
B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med (2003) 1.89
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med (2008) 1.88
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest (2001) 1.85
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J (1993) 1.82
The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol (2008) 1.79
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med (1996) 1.58
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57
Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med (1994) 1.49
Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49
Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood (2011) 1.48
Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A (2000) 1.43
CD5 maintains tolerance in anergic B cells. J Exp Med (2000) 1.42
Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol (2009) 1.41
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J Immunol (2006) 1.41
MicroRNAs prevent the generation of autoreactive antibodies. Immunity (2010) 1.38
STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol (2011) 1.37
Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 1.36
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc Natl Acad Sci U S A (1997) 1.34
MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med (2002) 1.29
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med (1997) 1.26
The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys (2008) 1.23
Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med (1999) 1.23
BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol (2008) 1.20
Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A (1992) 1.19
Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med (1997) 1.18
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med (2006) 1.17
Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med (1998) 1.17
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med (1993) 1.17
Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition. J Immunol (2010) 1.16
Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med (2012) 1.15
Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol (2009) 1.12
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs (2010) 1.12
The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity. Ann Rheum Dis (2006) 1.11
Role of Syk in B-cell development and antigen-receptor signaling. Proc Natl Acad Sci U S A (2000) 1.11
Receptor editing in self-reactive bone marrow B cells. The Journal of Experimental Medicine. 1993. 177: 1009-1020. J Immunol (2011) 1.10
Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J Immunol (2013) 1.10
Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09
Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol (2011) 1.08
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
B cells and autoimmunity. Curr Opin Immunol (2011) 1.06
Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J Exp Med (1999) 1.06
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev (2013) 1.05
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J Clin Invest (1999) 1.05
The transcription factor KLF2 restrains CD4⁺ T follicular helper cell differentiation. Immunity (2015) 1.04
A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J (1994) 1.02
Loss of the proapoptotic protein, Bim, breaks B cell anergy. J Exp Med (2006) 1.01
A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity (2010) 1.01
Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J Virol (2004) 1.01
Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc Natl Acad Sci U S A (1995) 1.00
Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. Proc Natl Acad Sci U S A (1998) 1.00
The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99
Activation and negative selection of functionally distinct subsets of antibody-secreting cells by influenza hemagglutinin as a viral and a neo-self antigen. J Exp Med (1996) 0.99
B-cell antigen-receptor signalling in lymphocyte development. Immunology (2003) 0.99
Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. Proc Natl Acad Sci U S A (2011) 0.97
A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol (2008) 0.96
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol (2010) 0.95
Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination. Curr Opin HIV AIDS (2014) 0.95
Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J Virol (2005) 0.94
Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J Exp Med (1993) 0.93
B cells in autoimmune diabetes. Rev Diabet Stud (2005) 0.93
Central B-cell tolerance: where selection begins. Cold Spring Harb Perspect Biol (2012) 0.92
Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing. Mol Cell Biol (2007) 0.92
Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harb Perspect Med (2012) 0.92
Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods (2010) 0.92
Restoring the balance: immunotherapeutic combinations for autoimmune disease. Dis Model Mech (2014) 0.92
Positive selection of B cells expressing low densities of self-reactive BCRs. J Exp Med (2004) 0.92
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J Exp Med (1997) 0.91
Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol (2009) 0.90
Loss of surface immunoglobulin expression precedes B cell death by apoptosis in the bursa of Fabricius. J Exp Med (1995) 0.90
Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol (2012) 0.89
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells. J Immunol (2008) 0.89
The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med (2003) 0.89
Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature (1997) 9.99
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Defective B cell development and function in Btk-deficient mice. Immunity (1995) 4.20
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature (1995) 2.95
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity (1995) 2.55
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity (1998) 2.42
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity (1997) 2.34
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell (1996) 2.09
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial. J Rheumatol (2001) 1.95
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med (1995) 1.91
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol Rev (2000) 1.89
Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity (1995) 1.88
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Breakdown of self-tolerance in anergic B lymphocytes. Nature (1991) 1.87
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Genome-wide ENU mutagenesis to reveal immune regulators. Immunity (2001) 1.76
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun (2005) 1.66
Positive versus negative signaling by lymphocyte antigen receptors. Annu Rev Immunol (1998) 1.66
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
A genomic view of immunology. Nature (2001) 1.66
Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models. Open Biol (2012) 1.65
CD43 (S7) expression identifies peripheral B cell subsets. J Immunol (1994) 1.64
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol (1994) 1.61
Stimulus control and generalization of point-loss punishment with humans. J Exp Anal Behav (2000) 1.61
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity (1997) 1.55
Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int Immunol (1992) 1.52
How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature (2000) 1.50
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature (1996) 1.47
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. J Immunol (1997) 1.41
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
Layered evolution in the immune system. A model for the ontogeny and development of multiple lymphocyte lineages. Ann N Y Acad Sci (1992) 1.36
Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci (1992) 1.36
A randomized controlled trial of a passive accessory joint mobilization on acute ankle inversion sprains. Phys Ther (2001) 1.36
Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity (1997) 1.36
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity (1998) 1.30
B-cell lineages exist in the mouse. Immunol Today (1993) 1.30
Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol (1994) 1.30
Frequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol (1997) 1.29
Cy7PE and Cy7APC: bright new probes for immunofluorescence. Cytometry (1996) 1.28
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med (1997) 1.26
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav (2006) 1.24
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Self tolerance in the B-cell repertoire. Immunol Rev (1991) 1.22
Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med (1998) 1.21
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ (2010) 1.20
Expression of T-cell receptor alpha-chain genes in transgenic mice. Mol Cell Biol (1988) 1.20
Danger - pathogen on the premises! Immunological tolerance. Curr Biol (1996) 1.19
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
Secretion of a chimeric T-cell receptor-immunoglobulin protein. Proc Natl Acad Sci U S A (1987) 1.17
Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry (2004) 1.16
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int Immunol (1992) 1.15